The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

CVS Caremark Appoints Dr. Alan Lotvin Executive Vice President of Specialty Pharmacy

Thursday, October 18, 2012

CVS Caremark Appoints Dr. Alan Lotvin Executive Vice President of Specialty Pharmacy10:00 EDT Thursday, October 18, 2012WOONSOCKET, R.I., Oct. 18, 2012 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today announced the appointment of Alan Lotvin, MD to the position of Executive Vice President, Specialty Pharmacy.  In this role, Dr. Lotvin will have overall responsibility for the company's Specialty Pharmacy strategy with a focus on identifying opportunities for growth and innovation in this fast-growing segment of the health care industry.  (Logo:  http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) Dr. Lotvin has extensive experience in the pharmaceutical benefit management and specialty pharmacy industries.  Prior to joining CVS Caremark, Dr. Lotvin was President and Chief Executive Officer of ICORE Healthcare, a Magellan Health Services company.  Previously, he has held roles as President and Chief Operating Officer of M|C Communications, a leading medical education provider, and served in various senior management positions at Medco Health Solutions, including President of Specialty Pharmacy Services."Specialty Pharmacy is an increasingly important growth area for CVS Caremark and Alan's in-depth experience and knowledge of the industry make him uniquely qualified to lead this portion of our business," commented Jon Roberts, President of the CVS Caremark PBM business.  "His expertise will enable us to continue to grow our specialty pharmacy leadership and identify opportunities for ongoing innovation to enable us to better help patients dealing with complex, debilitating diseases." "I am looking forward to working with the team at CVS Caremark to continue to grow and build upon the company's Specialty Pharmacy offerings," said Dr. Lotvin. "With specialty drugs estimated to account for seven of the top 10 drugs in the US by 2016, we need to continue to develop programs and solutions that will help our clients improve outcomes for these complicated diseases while managing cost and ensuring appropriate utilization." Dr. Lotvin is a cardiologist with a Medical Degree from the State University of New York Health Sciences Center in Brooklyn and a Masters Degree in Medical Informatics from Columbia University. About CVS CaremarkCVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,400 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 60 million plan members; and its retail health clinic system, the largest in the nation with more than 600 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans.  As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases such as diabetes obtain and stay on their medications.  Find more information about how CVS Caremark is reinventing pharmacy for better health at info.cvscaremark.com.Media Contact:Christine CramerCVS Caremark(401) 770-3317 christine.cramer@cvscaremark.com SOURCE CVS Caremark